Publications by authors named "David A Hollander"

Claim this Profile
L
Long-Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN-Open-Label Study.
Peter McAllister, Atul T Patel, Marta Banach, Aaron Ellenbogen, Jaroslaw Slawek, David A Hollander

Mov Disord Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of DaxibotulinumtoxinA for injection in adults with cervical dystonia: Pooled global analysis of ASPEN-1 and ASPEN-1-CN randomized trials.
Aaron Ellenbogen, Hu Xingyue, Jin Lingjing, Marta Banach, Atul T Patel, David A Hollander

Parkinsonism Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. 2024, , 442".
Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, Rashid Kazerooni, Todd M Gross, David A Hollander

Toxins (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA.
Aaron Ellenbogen, Robert A Hauser, Atul T Patel, Peter McAllister, Todd M Gross, David A Hollander

Toxins (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.
Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen, Rashid Kazerooni, Todd M Gross, David A Hollander

Toxins (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET).
Makoto Araie, Kazuhisa Sugiyama, Kenji Aso, Koji Kanemoto, Ryo Iwata, David A Hollander

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHASE 2 RANDOMIZED STUDY (ORION-1) OF A NOVEL, BIODEGRADABLE DEXAMETHASONE IMPLANT (AR-1105) FOR THE TREATMENT OF MACULAR EDEMA DUE TO CENTRAL OR BRANCH RETINAL VEIN OCCLUSION.
Michael A Singer, David S Boyer, Stuart Williams, Hayley McKee, Kevin Kerr, David A Hollander

Retina· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy.
Richard L Lindstrom, Amber E Lewis, Edward J Holland, John D Sheppard, John A Hovanesian, David A Hollander

J Ocul Pharmacol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).
David L Wirta, Michelle Senchyna, Amber E Lewis, David G Evans, Eugene B McLaurin, David A Hollander

Ocul Surf· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease.
David Wirta, Gail L Torkildsen, Blair Boehmer, David A Hollander, Edward Bendert

Cornea· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study.
Hiroshi Fujishima, Tomoko Hasunuma, Tetsuya Kawakita, Takuro Sekiya, Paul Gomes, David A Hollander

Ocul Immunol Inflamm· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.
Makoto Araie, Kazuhisa Sugiyama, Kenji Aso, Koji Kanemoto, Kalyani Kothapalli, David A Hollander

Adv Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment.
Guruprasad R Pattar, Gary Jerkins, David G Evans, Gail L Torkildsen, George W Ousler, David A Hollander

Ocul Surf· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study.
Hiroshi Nakatani, Paul Gomes, Ron Bradford, Qiang Guo, Eleonora Safyan, David A Hollander

Ocul Immunol Inflamm· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration.
John D Rodriguez, Keith Lane, David A Hollander, Aron Shapiro, Sunita Saigal

Clin Ophthalmol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
Peter J McDonnell, Stephen C Pflugfelder, Michael E Stern, David R Hardten, Taryn Conway, David A Hollander

BMC Ophthalmol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Sensitivity of Corneal TRPM8 Receptors to Menthol Instillation in Dry Eye Versus Normal Subjects.
Peter Corcoran, David A Hollander, George W Ousler, Endri Angjeli, David Rimmer

J Ocul Pharmacol Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of punctal occlusion on global tear proteins in patients with dry eye.
Louis Tong, Lei Zhou, Roger Beuerman, Susan Simonyi, David A Hollander

Ocul Surf· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of plateau iris syndrome with cataract extraction and endoscopic cyclophotocoagulation.
David A Hollander, Mark E Pennesi, Jorge A Alvarado

Exp Eye Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).
Kevin J Blinder, Pravin U Dugel, Sanford Chen, J Michael Jumper, John G Walt, David A Hollander

Clin Ophthalmol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.
Karl G Stonecipher, Gail L Torkildsen, George W Ousler, Scot Morris, Linda Villanueva, David A Hollander

Clin Ophthalmol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Punctal Occlusion on Clinical Signs and Symptoms and on Tear Cytokine Levels in Patients with Dry Eye.
Louis Tong, Roger Beuerman, Susan Simonyi, David A Hollander, Michael E Stern

Ocul Surf· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Pravin U Dugel, Antonio Capone, Michael A Singer, Richard F Dreyer, David G Dodwell, David A Hollander

BMC Ophthalmol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials.
Joseph B Ciolino, Eugene B McLaurin, Nicholas P Marsico, Stacey L Ackerman, Julia M Williams, David A Hollander

Clin Ophthalmol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Michael A Singer, Antonio Capone, Pravin U Dugel, Richard F Dreyer, David G Dodwell, David A Hollander

BMC Ophthalmol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis